Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH

Key figures

• Founded: 1997
• Employees: 45
• expert service in preclinical research & development of new cancer drugs

• models for each preclinical development phase:
  • Target identification and validation
  • Lead optimization
  • Translational research
• Major R&D-Topics:
  • Biomarker research for targeted tumor therapy
  • Stem cell research

Products & Technologies

Our services and experiences cover the following fields of preclinical research:

• Determination of in vitro and in vivo antitumor activity of investigational compounds
• Identification & validation of targets and biomarkers
• Pharmacokinetic and biodistribution studies
• Toxicology and pathology
• Genetic profiling with RT-PCR, Affymetrix, Illumina, Sequencing (NGS)
• Humanized mouse models for immune oncology
• Tumor imaging and radiation studies

We offer

• Contract research solutions in Experimental Pharmacology & Oncology Research
• Consulting & Support for commercialization of new models or projects (www.conelis.org)
• Evaluation of individualized treatment options for cancer patients